期刊文献+

冠心病患者高敏C反应蛋白和血脂检测的临床意义 被引量:1

Clinical significance of high sensitivity C-reactive protein (CRP) and serum! ipids detection in coronary heart disease
下载PDF
导出
摘要 目的:探讨冠心病患者超敏C反应蛋白(high-sensitivity C-reactive protein,hs-CRP)与血脂检测的临床应用。方法:通过应用日本Hitachi7060全自动化分析仪检测126例冠心痛患者和50例健康体检者的血清hs-CRP、TC、TG、HDL-C、LDL-C、ApoA,、ApoB浓度,统计分析各组之间关系。结果:冠心痛各组患者血清hs-CRP、TC、TG、LDL-C、ApoB浓度均比健康对照组显著增高(P<0.05),两组ApoA1,浓度无明显差异,而HDL-C浓度冠心病各组明显低于健康对照组(P<0.05),冠心病各组血脂各指标浓度均无显著差异。结论:hs-CRP作为一种低水平炎症敏感标志物,可作为冠心病患者独立危险因素来评价冠心病患者的病情,在冠心病的发生发展中能较好地预测冠心痛的危险程度,冠心痛患者存在明显血脂代谢紊乱,但血脂代谢紊乱可能仅为发病基础,而血脂紊乱后致血管的病理变化和炎症反应才是导致冠心痛患者病情进一步恶化的原因,故临床中应联合检测血脂各项,特别是TC、TC/HDL-C的值,才能较准确预测冠心病患者冠脉事件的发生危险程度。 Objective: To discuss the clinical application of serum hs- CRP and lipids detection and the correlation between them in coro- nary heart disease. Methods: The levels of serum hs-CRP.TC,TG.HDL -C.LDL -C.APOA1 ,ApoB were all measured in 126 coronary heart disease and 50 normal eases. Results: The study shows that the coronary heafi disease group had higher level hs- CRP.TC.TG,LDL-C^APOB and lower level HDL -C than the control group.but the levels of serum lipids in coronary herut disease had no significance.Conclusion:The levels of serum ha - CRP is significantly associated - with serum lipids level and inflammatory response,and the hs- CRI might play an important role in the pathogenesis and state evolvement of coronary heart disease.and the metabolism of sentm lipids significantly turbulence.So the higherlevel of hs - CRP and serumlipids( espe-- cially TC and TC/HDL - C) is, thegreater nsk there wiU be for eoronanry heart disease.
作者 罗梅芳
出处 《内蒙古中医药》 2010年第9期5-6,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 超敏C反应蛋白 血脂 冠心病 hjgh-sensitivity C-reactive protein(hs-CRP) senun lipids coronary heart disease
  • 相关文献

参考文献3

二级参考文献27

  • 1WilliamL Roberts RachelS etal.Evaluation of four automatedHigh - sensitivity C- reactive protein methods: implications for clin-ical and epidemiological applications[J].Clin Chem,2000,4:461-468.
  • 2NaderR RussellP PaulM etal.Clinical efficacy of automatedHigh- sensitivity C - reactive protein assay[J].Clin Chem,1999,12:2136-2141.
  • 3[1]Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999, 340(2): 115-126.
  • 4[2]Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls[J]. Clin Chem Lab Med, 2001, 39(11):1171-1176.
  • 5[3]Whicher J, Rifai N, Biasucci LM. Markers of the acute phase response in cardiovascular disease: an update[J].Clin Chem Lab Med, 2001, 39(11):1054-1064.
  • 6[4]Rifai N, Ridker PM. High-sensitivity C-reactive protein:a novel and promising marker of coronary heart disease [J]. Clin Chem, 2001,47(3):403-411.
  • 7[5]Morley JJ, Kushner I. Serum C-reactive protein levels in disease[J]. Ann N Y Acad Sci, 1982,389:406-418.
  • 8[8]Rothkrantz-Kos S, Schmitz MP, Bekers O, et al. Highsensitivity C-reactive protein methods examined[J]. Clin Chem, 2002,48(2): 359-362.
  • 9[9]Ferreiros ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina [J]. Circulation, 1999,100 (19):1958-1963.
  • 10[10]Morrow DA, Rifai N, Antman EM, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy[J]. J Am Coll Cardiol ,1998; 31(7): 1460 -1465.

共引文献129

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部